In Vitro Evaluation of Caffeoyl and Cinnamoyl Derivatives as Potential Prolyl Oligopeptidase Inhibitors

Abstract

A screening of the natural product chlorogenic acid, isolated from the Brazilian medicinal plant Hypericum brasiliense, caffeic acid, cinnamic acid, and p-methoxycinnamic acid, and derivatives of caffeoylquinic, caffeoyl, and cinnamoyl against the enzymes prolyl oligopeptidase and dipeptidyl peptidase IV was carried out. Caffeoylquinic, caffeoyl, and cinnamoyl derivatives were prepared using simple derivatization procedures and through coupling reactions with the amino acid proline. The dipeptidyl peptidase IV assay showed inhibitory activity of the tested compounds at a high concentration (500 µM) in the range of 81.5–7.2 %. In contrast, the derivatives methyl ester and 1,7-acetonide obtained from chlorogenic acid, and caffeic acid and its methyl ester derivative showed selectivity and activity as prolyl oligopeptidase inhibitors, with IC₅₀ values of 3 to 14 mM.

Key words

prolyl oligopeptidase - dipeptidyl peptidase IV - chlorogenic acid - caffeoyl and cinnamoyl derivatives - Hypericum brasiliense - Hypericaceae

• References

• 1 Garcia-Horsman JA, Männistö PT, Venäläinen JI. On the role of prolyl oligopeptidase in health and disease. Neuropeptides 2007; 41: 1-24
• 2 Polgar L. Prolyl oligopeptidases. Method Enzymol 1994; 244: 188-200
• 3 Yoshimoto T, Kado K, Matsubara F, Koriyama N, Kaneto H, Tsura D. Specific inhibitors for prolyl endopeptidase and their anti-amnesic effect. J Pharmacobiodyn 1987; 10: 730-735
• 4 Toide K, Iwamoto Y, Fujiwara T, Abe H. JTP-4819: a novel prolyl endopeptidase inhibitor with potential as a cognitive enhancer. J Pharmacol Exp Ther 1995; 274: 1370-1378
• 5 Shinoda M, Toide K, Ohsawa I, Kohsaka S. Specific inhibitor for prolyl endopeptidase suppresses the generation of amyloid beta protein in NG108–15 Cells. Biochem Biophys Res Commun 1997; 235: 641-645
• 6 Toide K, Okamiya K, Iwamoto Y, Kato T. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on prolyl endopeptidase activity and substance P- and arginine-vasopressin-like immunoreactivity in the brains of aged rats. J Neurochem 1995; 65: 234-240
• 7 Männistö PT, Venäläinen JI, Jalkanen AJ, Garcia-Horsman JA. Prolyl oligopeptidase: a potential target for the treatment of cognitive disorders. Drugs News Perspect 2007; 20: 293-305
• 8 Robner S, Schulz I, Zeitschel U, Schliebs R, Bigl V, Demuth HU. Brain prolyl endopeptidase expression in aging, APP transgenic mice and Alzheimerʼs disease. Neurochem Res 2005; 30: 695-702
• 9 Tarragó T, Kichik N, Claasen B, Prades R, Teixidó M, Giralt E. Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor. Bioorg Med Chem 2008; 16: 7516-7524
• 10 Filho AG, Morel AF, Adolpho L, Ilha V, Giralt E, Tarragó T, Dalcol II. Inhibitory effect of verbascoside isolated from Buddleja brasiliensis Jacq. ex Spreng on prolyl oligopeptidase activity. Phytother Res 2012; 26: 1472-1475
• 11 Green BD, Flatt PR, Bailey CJ. Dipeptidil peptidase IV (DPP IV) inhibitors: A newly emerging drug class for the treatment of type 2 diabetes. Diabet Vasc Dis Res 2006; 3: 159-165
• 12 Dalcol II, Adolpho L, Tarrago T, Kichik N, Morel A, Giralt E. Inhibitory effects of three species of Hypericum on POP and DPP IV activities. Anales del VI International Symposium on Natural Products and Its Applications. Chillán, CL: Universidad del Bio-Bio; 2007
• 13 Lopez Giraldo LJ, Laguerre M, Lecomte J, Figueroa-Espinoza MC, Barouh N, Baréa B, Villeneuve P. Lipase-catalyzed synthesis of chlorogenate fatty esters in solvent-free medium. Enzyme Microb Technol 2007; 41: 721-726
• 14 Selfkow M, Kelling A, Schilde U. First efficient synthesis of 1-, 4-, and 5-caffeoylquinic acid. Eur J Org Chem 2001; 2001: 2735-2742
• 15 Kim SS, Lee CK, Kang SS, Jung H, Choi JS. Chlorogenic acid, an antioxidant principle from the aerial parts of Artemisia iwayomogi that acts on 1,1-diphenyl-2-picrylhydrazyl radical. Arch Pharm Res 1997; 20: 148-154
• 16 Ma CM, Kully M, Khan JK, Hattori M, Daneshtalab M. Synthesis of chlorogenic acid derivatives with promissing antifungal activity. Bioorg Med Chem 2007; 15: 6830-6833
• 17 Li YL, Xu WF. Design, synthesis, and activity of caffeoyl pyrrolidine derivatives as potential gelatinase inhibitors. Bioorg Med Chem 2004; 12: 5171-5180
• 18 Zhu X, Dong X, Wang Y, Ju P, Luo S. Phenolic Compounds from Viburnum cylindricum . Helv Chim Acta 2005; 88: 339-342
• 19 Etzenhouser B, Hansch C, Kapur S, Dias Selassie C. Mechanism of toxicity of esters of caffeic and dihydrocaffeic acids. Bioorg Med Chem 2001; 9: 199-209
• 20 Salmi C, Brunel J, Vidal N, Letourneux Y. Scope and limitations of an efficient peptide coupling method. Lett Org Chem 2005; 2: 628-633
• 21 Bodanszky M, Bodanszky A. The pratice of peptide synthesis. Berlin, New York: Springer-Verlag; 1984: 284
• 22 Tarragó T, Sabido E, Kogan MJ, de Oliveira E, Giralt E. Primary structure, recombinant expression and homology modelling of human brain prolyl oligopeptidase, an important therapeutic target in the treatment of neuropsychiatric diseases. J Pept Sci 2005; 11: 283-287
• 23 Marques MR, Stuker C, Kichik N, Tarragó T, Giralt E, Morel AF, Dalcol II. Flavonoids with prolyl oligopeptidase inhibitory activity isolated from Scutellaria racemosa Pers. Fitoterapia 2010; 81: 552-556
• 24 Tarragó T, Kichik N, Segui J, Giralt E. The natural product berberine is a human prolyl oligopeptidase inhibitor. Chem Med Chem 2007; 2: 354-359
• 25 Lee JH, Lee SY, Lee KS, Jang HJ, Lee KH, Hahn TR, Paik YS. Prolyl endopeptidase inhibitors from the leaves of Gingko biloba . Planta Med 2004; 70: 1228-1230
• 26 Park DH, Park SJ, Kim JM, Jung WY, Ryu JH. Subchronic administration of rosmarinic acid, a natural prolyl oligopeptidase inhibitor, enhances cognitive performances. Fitoterapia 2010; 81: 644-648
• 27 Sultanova N, Makhmoor T, Yasin A, Abilov ZA, Omurkamzinova VB. Isotamarixen – a new antioxidant and prolyl endopeptidase-inhibiting triterpenoid from Tamarix hispida . Planta Med 2004; 70: 65-67
• 28 Checler F, Vicent JP, Kitabgi P. Inactivation of neurotensin by rat brain synaptic membranes partly occurs through cleavage at the Arg8-Arg9 peptide bond by metalloendopeptidase. J Neurochem 1985; 45: 1509-1513